Calendar

Apr
26
Sat
2014 Huaxia Health Technology Assessment Forum @ Courtyard at Marriott Hong Kong Shatin, Hong Kong, China
Apr 26 – Apr 27 all-day

20140426ISPOR_PosterTheme: Health Technology Assessment: Impact on Health Care and Assessment of the Value of Medicines

Organizers: ISPOR Hong Kong Chapter and The Chinese University of Hong Kong

Co-organizers: ISPOR Asia Consortium, Shanghai Chapter and Beijing Chapters

Mar
28
Sat
2015 Hong Kong Pharmacy Conference @ S220 Meeting Room, Hong Kong Convention & Exhibition Centre, Wanchai, Hong Kong
Mar 28 – Mar 29 all-day
Jun
25
Thu
2015 Workshop on “Novel Delivery Platforms for Patient-centered Therapeutics” @ G02, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39 , CUHK
Jun 25 @ 8:45 am – 5:00 pm

Date: 25 June 2015 (Thursday)20150625_Novel_Banner
Venue: G02, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39 , CUHK
Time: 08:45a.m. – 5:00p.m.

Customizing drug delivery to treat patients burdened with a myriad of diseases in a therapeutically and cost effective manner while meeting the vigorous regulatory standards of quality is a formidable challenge in personalized medicine. This is underscored by the important decision making role of the patient in determining the therapeutic outcome, a phenomenon commonly referred to as adherence. The objective of this one-day workshop is to highlight multidisciplinary research intended to benefit the elderly. Professor Ping I. Lee, an eminent scholar in mass transport at the University of Toronto, will keynote the scientific principles that underline the technologies of modified drug release, including those intended for nasal, pulmonary, and direct intravitreal administration. Furthermore, patients may also benefit from research in measuring blood-brain barrier permeability and from advances in digitally-based technologies for monitoring progress in drug therapy real time. In the final analysis, formulations designed to compensate for the deterioration in postural balance, manual dexterity, swallowing, and cognitive acuity commonly seen in the elderly is a timely development. Let’s not forget China alone could have some 400 million people over 60 years of age by 2050. Therefore, the market demand for such formulations could be substantial.

Photos

Sep
25
Fri
2015 Nanotechnology & Advanced Materials Symposium: Advanced Biomaterials and Nanotechnologies in Drug Delivery @ Room S226 – 228, Hong Kong Convention & Exhibition Centre
Sep 25 @ 2:00 pm – 5:00 pm
Feb
27
Sat
2016 Hong Kong Pharmacy Conference @ N101 Meeting Room, Hong Kong Convention & Exhibition Centre, Wanchai, Hong Kong
Feb 27 – Feb 28 all-day
Jul
16
Sat
2016 BABE Workshop @ LT3, YIA, CUHK
Jul 16 @ 9:00 am – 6:00 pm

20160716-H
Enquiry: Kate CHEUNG   /   (852) 3943-6831  /  sop.med@pharmacy.cuhk.edu.hk

Download the Programme / Abstracts / Power Point Files 

BABE Workshop
  1. Programme and Abstracts
Vinod P. SHAH
  1. Implementation of BABE Requirements at the FDA-Lessons Learned
  2. Immediate Release and Modified Release Bioequivalence Requirements
  3. Biowaivers – BCS and IVIVC
  4. Design and Regulatory Assessment of Transdermal Drug Products
  5. AAPS Video
Clive CHAN
  1. Regulatory Assessment of Critical Dose/NTR Drugs in Hong Kong
  2. Regulatory Assessment of Biosimilars in Hong Kong
Teddy LAM
  1. Combination Products – A Simulation Study of BABE

Please check out our School Facebook for more photos.

 

 

Feb
18
Sat
2017 Hong Kong Pharmacy Conference @ Meeting Rooms S220 series, Level 2, Phase 1 (Old Wing), Hong Kong Convention and Exhibition Centre, 1 Expo Drive, Wanchai, Hong Kong
Feb 18 – Feb 19 all-day
Mar
23
Thu
Distinguished Lecture Series 2017 – March @ CUHK
Mar 23 – Mar 24 all-day

20170322

Apr
6
Thu
Distinguished Lecture Series 2017 (6 & 7 April)
Apr 6 – Apr 7 all-day

20170405

Apr
19
Wed
Distinguished Lecture Series 2017 @ CUHK
Apr 19 – Apr 21 all-day

20170301-03-20170123rv

Comments are closed